VTGN
Vistagen Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Vistagen Therapeutics (VTGN) Stock: Buy, Sell, or Hold?
$0.18
-0.01 (-4.79%)
▼
5d:
+8.23%
30d:
-13.46%
90d:
-33.18%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (90%)
Quality Score
57/100
Position
SLIGHTLY LOW
30-Day Fair Range
$0.17 – $0.24
Position: SLIGHTLY LOW
Forward P/E & Valuation
-0.2x
Next 12M consensus est.
Wall Street Target
$1.00
+459.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.16 / $0.19
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: VTGN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
Get Alerted When VTGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VTGN is currently trading at $0.18, which is considered slightly low relative to its 30-day fair value range of $0.17 to $0.24.
Technical Outlook: Technically, VTGN is in a downtrend. Immediate support is located at $0.16, while resistance sits at $0.19. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: VTGN scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.00 (+459.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VTGN is in a downtrend. Immediate support is located at $0.16, while resistance sits at $0.19. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: VTGN scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.00 (+459.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.17 -
$0.24
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
Trading Range & Key Levels
30-Day Trading Range
$0.17 -
$0.24
Current vs Trading Range
SLIGHTLY LOW
Support Level
$0.16
Resistance Level
$0.19
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (66/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 459.3% below Wall St target ($1.00)
- BULLISH: Bottoming setup score 66/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-0.18
Wall Street Target
$1.00
(+459.3%)
Revenue Growth (YoY)
504.9%
Share VTGN Analysis
Share this live VTGN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VTGN)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
A user on StockTwits expresses bullish sentiment towards ADVB, predicting a potential low float squeeze and encouraging traders to add it to their watchlist.
Key Retail Themes:
bullish sentiment
low float squeeze potential
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:22 AM ET
Data refreshes hourly during market hours. Next update: 6:22 AM
Data refreshes hourly during market hours. Next update: 6:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VTGN Research Pages
